He Hui Ying

/ 50, SCI 22. 17.521. 12 、, 《 》 《 》..,,,;,. 1. 2008 8 -,, 、PBL、 、; 、 、 、 、. 2.;;;;;;;;;;. 3. 《 》、《 》、International Journal of Oncology、Oncotarget、Oncology Letters、Molecular and Clinical Oncology 4. 《 》 、《 》 、《BMJ quality and safety》 2012;2013;2015;2015 7;2016;2017;2018;2020 、2021;2020 SCI 1. Wang X, Li W, Feng Y, Liu L, He H*, Li B*. Unicystic Mucoepidermoid Carcinoma: A Pitfall for Clinical and Pathologic Diagnosis. J Oncol. 2022 Sep 13;2022:2676367.(IF 4.501) 2. Ge G, Han Y, Zhang J, Li X, Liu X, Gong Y, Lei Z, Wang J, Zhu W, Xu Y, Peng Y, Deng J, Zhang B, Li X, Zhou L, He H*, Ci W*. Single-Cell RNA-seq Reveals a Developmental Hierarchy Super-Imposed Over Subclonal Evolution in the Cellular Ecosystem of?Prostate?Cancer.Adv Sci (Weinh). 2022 May;9(15):e2105530. (IF 17.521 3. Zhao M, He H*, Cao D, Fan D, Xu M, Zhang X, Ru G. Solitary Fibrous Tumor with Extensive Epithelial Inclusions: Clinicopathologic and Molecular Study of Three Cases of an Underrecognized Variant in Abdominopelvic Sites. Am J Clin Pathol. 2022 Feb 9:aqac023. (IF 5.400) 4. Chi X, Luo W, Song J, Li B, Su T, Yu M, Wang T, Wang Z, Liu C, Li Z, He H*, Zhan J, Zhang H. Kindlin-2 in Sertoli cells is essential for testis development and male fertility in mice. Cell Death Dis. 2021 Jun 11;12(6):604. (IF 8.469) 5. Tian X, Hong P, Tang S, Liu Z, Yang F, Zhang S, Wang G, He H*, Ma L. Urothelial carcinoma of the renal pelvis with renal vein and inferior vena cava tumor thrombus: case series and literature review. Transl Androl Urol. 2021 Jul;10(7):2879-2888.(IF 3.15) 6. Wang Y, Zhang JX, Wang SF, Zhang Y, He HY*. Expression of the epigenetic H3K27me3 modifier genes KDM6A and EZH2 in patients with upper tract urothelial carcinoma. Oncol Lett. 2020 Dec;20(6):349(IF 2.311) 7. Li B, Jie W, He H*. Myb Immunohistochemical Staining and Fluorescence in situHybridization in Salivary Rare Basaloid Lesions. Front Oncol. 2020 Jun 30;10:870. (IF 4.848) 8. ZhengZheng Xu; Guangzhe Ge; Bao Guan; Zhentao Lei; Xueyu Hao; Yuanyuan Zhou; Yue Shi; Huan Lu; Jilu Wang; Ding Peng; XiKang Wu; Huiying He*; Bao Zhang*; Xuesong Li*; Liqun Zhou*; Weimin Ci*. Non-invasive detection and localization of genitourinary cancers using urinary sediment DNA methylomes and copy number profiles. Eur Urol 2020Feb;77(2):288-290 (17.298) 9. Yue Wang, Jinxia Zhang, Yunfan Wang, Shufang Wang, Yu Zhang, Qi Miao, Fei Gao, Huiying He* Expression status of GATA3 and mismatch repair proteins in upper tract urothelial carcinoma. Front Med. 2019 Dec;13(6):730-740. (3.113) 10. He H#, Trpkov K, Martinek P, Isikci OT, Maggi-Galuzzi C, Alaghehbandan R, Gill AJ, Tretiakova M, Lopez JI, Williamson SR, Montiel DP, Sperga M, Comperat E, Brimo F, Yilmaz A, Pivovarcikova K, Michalova K, Slouka D, Prochazkova K, Hora M, Bonert M, Michal M, Hes O. "High-grade oncocytic renal tumor": morphologic, immunohistochemical, and molecular genetic study of 14 cases. Virchows Arch. 2018,473(6): 725-738. 11. Li M, Pei X, Wang G, Zhan J, Du J, Jiang H, Tang Y, Zhang H*, He H*. Kindlin-2 regulates clear cell renal cell carcinoma progression through the Wnt signaling pathway and has prognostic value for CCRCC. Oncol Rep, 2017;38(3):1551-1560. 12. Pei X#, Li M, Zhan J, Yu Y, Wei X, Guan L, Aydin H, Elson P, Zhou M, He H*, Zhang H(*). Enhanced IMP3 Expression Activates NF-кB Pathway and Promotes Renal Cell Carcinoma Progression. PLoS One. 2015;10(4):e0124338. (IF:3.234) 13. Xing TY#, He HY*. Epigenomics of clear cell renal cell carcinoma: mechanisms and potential use in molecular pathology. Chin J Cancer Res. 2016;28(1):80-91. review (IF 2.201) 14. He H#, Magi-Galluzzi C*. Epithelial-to-mesenchymal transition in renal neoplasms. Adv Anat Pathol. 2014;21(3):174-180. (IF3.1) 15. He H#, Osunkoya AO, Carver P, Falzarano S, Klein E, Magi-Galluzzi C, Zhou M(*). Expression of ERG Protein, A Prostate Cancer Specific Marker, in High Grade Prostatic Intraepithelial Neoplasia (HGPIN): Lack of Utility to Stratify Cancer Risks Associated with HGPIN. BJU Int. 2012;110(11B):E751-755. (IF 2.844) 16. He H#, Zhou GX, Zhou M, Chen L. The distinction of clear cell carcinoma of the female genital tract, clear cell renal cell carcinoma, and translocation-associated renal cell carcinoma: an immunohistochemical study using tissue microarray. Int J Gynecol Pathol. 2011;30(5):425-30. 17. He H#, Magi-Galluzzi C, Li J, Carver P, Falzarano S, Smith K, Rubin M.A., Zhou M. The Diagnostic Utility of Novel Immunohistochemical Marker ERG in the Work-up of Prostate Biopsies with “Atypical Glands Suspicious for Cancer”. Am J of Surg Pathol. 2011,35(4):608-614 18. He H#, Somlo G, Yun Y, Chu PG. Dendritic Cell Infiltration in Lymph Node Positive Breast Carcinomas. The Breast J. 2009,15(2): 218–220. 19. He H#, Fang W, Liu X, Weiss LM, Chu PG. Frequent expression of glypican-3 in Merkel cell carcinoma: an immunohistochemical study of 55 cases. Appl Immunohistochem Mol Morphol. 2009,17(1):40-46. 20. He H#, Luthringer D, Hui P, Lau SK, Weiss LM, Chu PG. Expression of CD56 and WT1 in Ovarian Stroma and Ovarian Stromal Tumors. Am J of Surg Pathol. 2008, 32(6):884-890. 21. He H#, Cheng L, Weiss LM, Chu PG. Clinical outcome of incidental pelvic node malignant B-cell lymphomas discovered at the time of radical prostatectomy. Leukemia and lymphoma. 2007,48(10):1976– 1980. 22. Chen Ling *, He HY *, Li HM, et al. ERK1/2 and p38 pathways are responsible for P2Y receptor-mediated prostate cancer invasion. Cancer Letters. 2004, 215(2): 239–247. 、 、 、 《 》.,2018 12; 1. WHO classification of tumours of the urinary system and male genital organs fifth edtion IARC 2022 6 2. 《 》 2022 3 3. 《 》 2022 3 4. 《 - 》 2020 11 5. 《 》( 3 ) 2019 11 6. 《 》 2019 4 7. 《 》 2019 1,2009 12,2013 12 8. 《 》 2018 6 9. ( 2 ).. 2017 3 10. Atlas of practical genitourinary pathology. McGraw-Hill Education/Medical, 2014 11 11. 《 》..2014 9 1. 《 》 2022 9 2. 《 》( 11 ) 2021 3; 10,2014 1 3. 《 》.. 2018 1 4. 《 》( 6 )..2017 4 5. 《 》( 4 ).. 2017 1 6. 《 》( 3 ).. 2011 2 7. 《WHO: 》.2006 10